Page last updated: 2024-10-30

leflunomide and Anti-GBM Disease

leflunomide has been researched along with Anti-GBM Disease in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chow, KM1
Szeto, CC1

Other Studies

1 other study available for leflunomide and Anti-GBM Disease

ArticleYear
Leflunomide and anti-glomerular basement membrane glomerulonephritis: comment on the letter by Bruyn et al.
    Arthritis and rheumatism, 2004, Volume: 50, Issue:1

    Topics: Animals; Anti-Glomerular Basement Membrane Disease; Humans; Immunosuppressive Agents; Isoxazoles; Le

2004